Fasenra subcutaneous injection 10mg syringe (YJ code: 2290402G2027, standard: 10mg 0.5mL x 1 tube) is an AstraZeneca medication containing Benralizumab (genetical recombination). It is indicated for severe eosinophilic asthma, with a 10mg dose typically used for children aged 6-11 years who weigh less than 35 kg.
Fasenra subcutaneous injection 10mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →